Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5)

Multiple myeloma advances for the future suggested by phase I clinical research

Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute

Investigation of Ki67 biomarker

Effects of obesity in breast cancer patients

A need for clarity in clinical trial end points

Expanding international collaboration at IFOM

Perception of inequalities in care and cancer registries

Development of clinical trials and biobanks

Ovarian cancer tumour banks and collaboration

The Merseyside and Cheshire cancer network

Drug approval process for ovarian cancer